Customer Service: 866-788-9007

Transforming the Management of Dermatologic Cancers

Enabling More Accurate Treatment Plan Decisions With Our Line of Gene Expression Profile (GEP) Tests

CUTANEOUS MELANOMA

Predicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma

Dx-Melanoma-2r

Squamous Cell Carcinoma

Better Identifies Risk of Metastasis in Patients With One or More Risk Factors

Dx-Melanoma-1r1

UVEAL MELANOMA

The Standard of Care for Uveal Melanoma Staging

Dx-Melanoma-1r11